foxo4-dri senolytic peptide human trial The disordered p53 transactivation domain is the target of FOXO4 and the compound FOXO4-DRI improves spermatogenesis in aged
Pay in 4 interest-free payments of $6.28 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Jul 27 - Aug 1




